Unexpectedly high exposure to enteric-coated mycophenolate sodium upon once-daily dosing

Pediatric Nephrology

Volumn 21, Issue 8, 2006, Pages 1206-1208

  Filler, Guido ^a   Lathia, Anita ^a   LeBlanc, Claire ^a   Christians, Uwe ^b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

EC MPS; MMF; Mycophenolate sodium; Mycophenolic acid; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; STEROID;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; CASE REPORT; CLINICAL FEATURE; DOSE KIDNEY FUNCTION RELATION; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; ENTERIC COATED TABLET; FAMILY HISTORY; FEMALE; GLOMERULUS FILTRATION RATE; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAINTENANCE THERAPY; PATIENT COMPLIANCE; PLASMAPHERESIS; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; RECURRENT DISEASE; REMISSION; RETREATMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT REFUSAL;

ADOLESCENT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYCOPHENOLIC ACID; OVERDOSE; TABLETS, ENTERIC-COATED;

EID: 33746170590     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0139-x     Document Type: Article

References (14)

1. Li L, Wang H, Lin S, Chen X, Chen Y, Xu J, Chen N, Li X, Qian J, Hu W (2002) Mycophenolate mofetil treatment for diffuse proliferative lupus nephritis: A multicentre clinical trial in China. Zhonghua Nei Ke Za Zhi 41:476-479
2. Spetie DN, Tang Y, Rovin BH, Nadasdy T, Nadasdy G, Pesavento TE, Hebert LA (2004) Mycophenolate therapy of SLE membranous nephropathy. Kidney Int 66:2411-24159
3. Pisoni CN, Karim Y, Cuadrado MJ (2005) Mycophenolate mofetil and systemic lupus erythematosus: An overview. Lupus 14(Suppl 1):s9-s11
4. Filler G, Hansen M, LeBlanc C, Lepage N, Franke D, Mai I, Feber J (2003) Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children. Pediatr Nephrol 18:445-449
5. Salvadori M, Holzer H, de Mattos A, Sollinger H, Arns W, Oppenheimer F, Maca J, Hall M, The ERL B301 Study Groups (2004) Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients. Am J Transplant 4:231-236
6. Behrend M, Braun F (2005) Enteric-coated mycophenolate sodium: tolerability profile compared with mycophenolate mofetil. Drugs 65:1037-1050
7. Budde K, Glander P, Diekmann F, Waiser J, Fritsche L, Dragun D, Neumayer HH (2004) Review of the immunosuppressant enteric-coated mycophenolate sodium. Expert Opin Pharmacother 5:1333-1345
8. Schutz E, Shipkova M, Armstrong VW, Niedmann PD, Weber L, Tonshoff B, Pethig K, Wahlers T, Braun F, Ringe B, Oellerich M (1998) Therapeutic drug monitoring of mycophenolic acid: Comparison of HPLC and immunoassay reveals new MPA metabolites. Transplant Proc 30:1185-1187
9. Salvadori M, ERLB301 Study Group (2001) Therapeutic equivalence of mycophenolate sodium versus mycophenolate mofetil in de novo renal transplant recipients. Transplant Proc 33:3245-3247
10. Ettenger R, Bartosh S, Choi L, Zhu W, Niederberger W, Campestrini J, Bastien MC, Schmouder R (2005) Pharmacokinetics of enteric-coated mycophenolate sodium in stable pediatric renal transplant recipients. Pediatr Transplant 9:780-787
11. Gabardi S, Tran JL, Clarkson MR (2003) Enteric-coated mycophenolate sodium. Ann Pharmacother 37:1685-1693
12. Hesselink DA, van Hest RM, Mathot RA, Bonthuis F, Weimar W, de Bruin RW, van Gelder T (2005) Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2. Am J Transplant 5:987-994
13. Christians U, Strom T, Zhang YL, Steudel W, Schmitz V, Trump S, Haschke M (2006) Active drug transport of immunosuppressants. New insights for pharmacokinetics and pharmacodynamics. Ther Drug Monit 28:39-44
14. Sugioka N, Koyama H, Ohta T, Kishimoto H, Yasumura T, Takada K (1996) Pharmacokinetics of mycophenolate mofetil, a new immunosuppressant, in rats. J Pharm Sci 85:335-338